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INTRODUCTION 28
Microglia are the primary innate immune cells in the CNS, capable of mounting inflammatory 29 responses and phagocytosis. They can be distinguished from other CNS cell types by the 30 distinctive ramified morphology and expression of common myeloid markers including Cd11b 31 and ionized calcium binding adaptor molecule 1 (Iba1). In addition to immune functions, microglia 32 carry out a multitude of neurotrophic functions during CNS development and homeostasis 33 (Kierdorf and Prinz, 2017) . Microglia also play critical pathological roles in a wide spectrum of 34 neurodegenerative conditions, including Alzheimer's disease, Parkinson's disease, Huntington's 35 disease, and Amyotrophic lateral sclerosis (Hickman et al., 2018) . A number of disease genes were 36 found to be highly expressed in microglia (Hansen et al., 2018) Unlike other CNS glial cells, microglia originate from the embryonic mesoderm and follow a 40 convoluted developmental journey (Rezaie and Male, 2002) . It starts with the emergence of c-kit+ 41 erythromyeloid progenitors in the yolk sac, known as primitive hematopoiesis, which then influx 42 into the developing parenchyma via circulation (Ginhoux et al., 2010) in an Irf-8, Pu.1-dependent 43 manner (Kierdorf et al., 2013) . Seeded microglial progenitors persist in the CNS and continue to 44 expand and mature until adulthood (Matcovitch-Natan et al., 2016). In general, developing 45 microglia can be distinguished by well-defined developmental intervals from the yolk sac to the 46 adult, and transcriptional programs associated with each of these stages have been meticulously 47 mapped (Matcovitch-Natan et al., 2016). In particular, homeostatic maturation in microglia 48 requires the transcriptional factor Mafb (Matcovitch-Natan et al., 2016) as well as TGF-beta 49 signaling (Butovsky et al., 2014; Zoller et al., 2018) , and can be distinguished by homeostatic 50 markers such as Tmem119 (Bennett et al., 2016) and P2ry12 (Haynes et al., 2006) . Interestingly, 51 we recently discovered that adult newborn microglia follow a similar maturation path (Zhan et al., 52 2019 ), suggesting that the developmental plasticity of microglia in the adult brain might be an 53 underlying feature of microglial homeostasis (Santambrogio et al., 2001) . Unlike other tissue 54 myeloid populations such as monocytes and macrophages, the resident microglial pool receives 55 no significant replenishment from circulation and is internally maintained by self-renewal ( (Fogg et al., 2006) . 63
Csf1r signaling is critical for microglial survival and maintenance. Loss-of-function mutation 64 is either of its two natural ligands: Csf1 and IL-34, results in significant reduction of microglia 65 count (Greter et al., 2012; Wegiel et al., 1998) . Null mutations in Csf1r remove 99.7% microglia, 66 but a few morphologically distinctive microglia near the hippocampus and piriform cortex remain 67 (Erblich et al., 2011) . In addition, the Csf1r inhibitor PLX5622 (PLX) has been widely used as a 68 research tool to acutely remove microglia. While depletion efficiency varies, complete microglial 69 ablation has never been reported (Acharya et al. . These studies suggest that the adult microglial pool includes a population that does 71 not require Csf1r signaling for survival. Remarkably, the microglial pool can be rapidly 72 regenerated after termination of PLX administration. While an earlier study proposed a hidden 73 nestin+ progenitor pool responsible for repopulation (Elmore et al., 2014) , we and others found 74 that the remaining microglia were solely responsible for microglial repopulation (Huang et al., 75 2018; Zhan et al., 2019) , consistent with the notion that a subpopulation of microglia exhibit 76 progenitor-like features. Our current study applied single-cell RNA-sequencing (scRNA-seq) to 77 examine the resilient microglial population after acute Csf1r inhibition with PLX. Among the 78 PLX-resistant microglia were a subpopulation of Mac2+ cells, which were also discovered in the 79 homeostatic microglial pool yet displayed unexpected progenitor signatures. We also examined 80 the role of the Mac2+ microglia during adult microgliogenesis in a microglia 81 depletion/repopulation model. 82
83

RESULTS
84
Single cell RNA-seq profiling of microglia under Csf1r inhibition and early repopulation 85
To examine the transcriptome profiles of the Csf1r inhibitor-resistant microglial population, we 86 performed scRNA-seq on the remaining microglia from C57/BL6J mice that were treated with 87 PLX diet (D0) ( Fig. 1A ). To investigate early stage adult newborn microglia, we also included 88 mice that were switched to a control diet for 2 days after PLX treatment (D2) ( Fig 1A) . Microglia 89 from age-matched non-treated mice were used as control (Ctrl) ( Fig 1A) . Similar to our previous 90 results (Zhan et al., 2019) , oral dosing of 1200 mg/kg PLX in C57/BL6J mice for two weeks 91 resulted 92.93 -96.2% removal of CD11b+ myeloid cells in the CNS ( Fig S1) . Single cell 92 suspensions were stained with CD11b antibody for myeloid population purification via 93 fluorescence activated cell sorting (FACS) ( Fig S1) , followed by the 10x genomics single cell 94 RNA-seq platform ( Fig 1B) . 95
After data filtering with QC metrics (Fig. S2 ), we obtained a total of 2,100 cells at a sequencing 96 depth of about 48,000 reads/cell ( Fig 1C) . A total of 653 variable genes were detected and the most 97 variable genes were detected from 2100 cells after initial data filtering ( Fig 1C) . Although the 98 number of cells sequenced from Ctrl, D0 and D2 differed, the sequencing quality was comparable, 99 as evidenced by UMI, total number of genes, and percentage of mitochondrial genes per cell ( Fig.  100 S2). Following initial principle component analyses ( Fig. S2 ), further data dimensional reduction 101 using t-distributed stochastic neighbor embedding (tSNE) (van der Maaten, 2008) identified 9 102 distinctive cell clusters ( Fig 1D) . Of note, Clusters 1-3 consisted primarily of the naive microglia 103 from control mice ( Fig 1E) , whereas cells from microglial depletion group (D0) and early 104 repopulation group (D2) were grouped together in Clusters 4-9 ( Fig 1E) . Specifically, in Clusters 105 1-3, 76%-100% of microglia were from control mice ( Fig. 1F -H) whereas less than 7% of 106 microglia were from control mice in Clusters 4-9 ( Fig. 1I-N In stark contrast to clusters derived from steady-state cells from control mice (Clusters 1-3), 113 microglial homeostatic genes were significantly down-regulated in the clusters enriched with D0 114 and D2 cells (Cluster 4-9) (Fig 2A) , including signature genes such as Tmem119 ( brain slices from C57/BL6J mice that were treated with PLX diet for 2 weeks (D0) and those from 118 Ctrl brains ( Fig 2H) . Iba1 was used as a microglial marker. The fluorescence intensity of P2ry12 119 and Tmem119 per Iba1+ cell was significantly decreased in D0 microglia compared with Ctrl 120 microglia ( Fig 2I, J) . 121 122
Cluster identification reveals heterogenous microglial populations under Csf1r inhibition 123
We next applied differentially expressed gene (DEG) analysis to obtain the transcriptomic profile 124 of each cluster. DEGs were selected based on log fold-change ratio either above 0.5 or below -0.5 125 ( Fig 3A and Table S1 ). Notably, while some of the marker genes were exclusively expressed in 126 certain clusters, many were shared among multiple clusters. Among the most upregulated genes, 127 each cluster could be identified with distinctive markers ( Fig 3B) . 128
In order to analyze the cell populations from each cluster in more detail, we manually compared 129 the most prominently expressed markers from each cluster with the tabula-muris dataset, a single-130 cell atlas that contains annotation data for 100,000 cells from 20 different organs and tissues 131 (Tabula Muris et al., 2018) ( Fig 3C) . Cluster-1 and Cluster-2 resembled homeostatic microglia, 132 with Cluster-1 expressing high-levels of homoeostatic genes including P2ry12, Tmem119 and 133 Trem2. Cluster-2 showed a similar homeostatic gene signature but also exhibited a modest increase 134 of NF-kB target genes including Ccl3, Ccl4, and Tnf ( Fig. 3C ). Microglia in Cluster-3 expressed 135 a high level of Mrc1, which encodes the meningeal macrophage marker CD206 (Goldmann et al., 136 2016) , and apolipoprotein E, the major risk factor in AD. Remarkably, this population was 137 completely wiped out by PLX treatment, as Cluster-3 was absent in both the D0 and D2 groups 138 ( Fig 1H) . Immunohistochemistry analysis validated this observation, showing complete loss of 139 CD206+ meningeal macrophages after 2 weeks of PLX treatment ( Fig 3D) . 140
Despite reduced expression of homeostatic microglial signatures, Clusters-4, -5, -8, -9 141 expressed myeloid markers as expected ( Fig. S3A) , with transcriptional profiles that resembled 142 monocytes (Cluster-4, Fig S3B) ; granulocytes (Cluster-5, Fig S3B) ; and dendritic cells 8, Fig S3F) . Specifically, cells in Cluster-8 expressed CD209a, and MHC genes such as H2-Ab1, 144 H2-Eb1, and CD74, a cell surface receptor for the cytokine macrophage migration inhibitory factor 145 (MIF). Immunohistochemistry analysis showed over-representation of CD74-positive microglia in 146 D0 brains, confirming that this cell population is resistant to csf1r inhibitors ( Fig. 3E ). In Cluster-147 9, the top-10 most upregulated genes were involved in mitosis, including Marker of Proliferation 148
Ki-67 (Mki-67), DNA Topoisomerase 2a (Top2a), Cyclin A2 (Ccna2), and Cyclin B2 (Ccnb2) 149 ( Fig 3C) . Consistent with this population representing proliferative microglia, the relative 150 frequency of cells in Cluster 9 roughly doubled its size from 30% (D0) to 69% in just two days of 151 microglial repopulation ( Fig 1N) . 152 Cells in Cluster-6 and Cluster-7 lacked myeloid markers including Cd11b, Csf1r, and Cd14 did 153 not ( Fig. S3A ). Instead, Cluster-6 showed high expression of Klrb1c and Nkg7, which are normally 154 found in natural killer (NK) cells ( Fig S3D) , while Cluster-7 expressed T-cell markers Ccr7 and 155 Il7r ( Fig S3E) . We then performed microglial lineage mapping using the Cx3cr1-CreERT2 and 156 inducible RFP reporter, and showed that microglia under Csf1r inhibition did not express either 157 the T cell marker CD3 or the NK cell marker Nkg7 (Fig. S4 ). Thus, it is unlikely that these are 158 microglia with altered states under Csf1r inhibition. Instead, it is more likely that certain subsets 159 of NK and memory T cells were captured by cd11b-based capture during FACS since they can all clusters, we revealed three branches in the pseudo-time trajectory tree: homeostatic, 165 proliferative, and PLX-resistant ( Fig 3F) . As expected, Clusters-6 and -7 were placed on the PLX-166 resistant branch ( Fig 3G) , because lymphocytes were not affected by PLX5622 (Wheeler et al., 167 2018 ). Among the myeloid clusters, Cluster-8 was evenly distributed along the PLX-resistant and 168 proliferative branches, while Clusters-4 and -5 were largely distributed along the PLX-resistant 169 branch ( Fig 3G) . 170
171
A unique Csf1r inhibition-resistant microglial population expresses Mac2 172
To spatially map the underlying PLX-resistant microglia from Cluster-4 and -5, we next searched 173 for markers that distinguish them via immunohistochemistry. Marker gene analysis in identified Mac2 antigen, also known as Galectin 3 (Lgals3), as a potential marker ( Fig 4A) . Lgals3 175 was highly expressed in Clusters-4, -5, -8, and -9 ( Fig 4B, C) . Immunofluorescence staining of 176 brain tissues from C57/BL6J mice that were treated with PLX diet for 2 weeks (D0) revealed a 177 subset of Iba1+ microglia expressing Mac2 in both Ctrl and D0 groups ( Fig 4D) , with increased 178 Mac2 intensity and more extensive ramification in the D0 mice. After 2 weeks of PLX treatment, 179 while the majority of Iba+ cells was depleted, showing 88% loss ( Fig. 4E ), the number of 180 Iba1+Mac2+ cells was modestly increased (D0) in the hippocampus ( Fig 4F) . Notably, Mac2+ 181 microglia accounted for approximately 0.68% ± 0.16 (SEM) of all Iba1+ microglia in adult 182 hippocampus; the frequency dramatically increased to 15.46% CreERT2/STOP flox -RFP). One month after the initial tamoxifen injection, 98% labeled monocytes 194 in circulation are replaced by unlabeled newborn cells, whereas microglia in the brain remain 195 RFP+ due to their extreme longevity (Parkhurst et al., 2013) . Using a similar labeling strategy, we 196 examined the lineage of the parenchymal Mac2+ cells ( Fig 5A) . We reasoned that if the Mac2+ 197 microglia were derived from circulating monocytes/macrophages that lack RFP expression, there 198 would be fewer Mac2+ microglia that express RFP after repeated PLX treatment. Instead, RFP 199 labeling efficiency in the Mac2+ population did not differ after either single (PLX 1X ) or tandem 200 PLX treatment (PLX 2X ) separated by a repopulation period (Fig 5 B-D) , indicating that the Mac2+ 201 cells are not derived from circulating monocytes, but rather resident microglia that are internally 202 maintained in the parenchyma. 203
We then examined the newborn microglia at day 4 and day 14 after switching mice from PLX 204 diet to the control diet using 5-Ethynyl-2'-deoxyuridine (EdU) pulse-chase labeling. To maximize 205 the EdU labeling efficiency, two sequential intraperitoneal injections separated by 7 hours apart 206 were given on repopulation day 3 ( Fig 5E) . In the ectorhinal cortex, we confirmed microglia 207 repopulation ( Fig 5F-H) and found that, while a subset of both Mac2+ and Mac2-microglia have 208 incorporated Edu (Fig 5F, G) , the number of Iba1+Mac2+ cells increased substantially at 209 repopulation day 4 (D4) ( Fig 5I) , accounting for ~5% of total Iba1+ microglia ( Fig 5J) . Roughly 210 50% of the Iba1+Mac2+ cells were EdU+ at repopulation Day 4 ( Fig 5K) . Their highly 211 proliferative property was further supported by the presence of mitotic marker Ki67 ( Fig S5) . 212
Notably, newborn cells in the Iba1+Mac2+ population failed to retain Mac2+ expression over long 213 term, and the number of Iba1+Mac2+ cells dropped back to control level after repopulation day 214 14 ( Fig 5I) . 215 216
Mac2+ cells display microglial progenitor signatures 217
To further characterize the Mac2+ microglial population, we selected the Mac2+ cells from our 218 scRNA-seq dataset based Lgals3 expression one standard deviation above the average log UMI 219 counts. A total of 504 cells were manually distinguished and binned together as the Mac2+ cluster 220 ( Fig 6A) . Overlay of the Mac2+ cells on the tSNE plot showed that they were largely derived from 221
Clusters -4, -5, -8, -9, with only a few sprinkled in the homeostatic Clusters-1 and -2 ( Fig 6A) . To 222 investigate the gene signatures in Mac2+ cells, we next performed DEG analysis in comparison to 223 homeostatic Cluster-1 ( Fig 3C) . DEGs were identified that showed log fold-change ratio above 0.5 224 for upregulated (UP) genes or below -0.5 for downregulated (DN) genes. We identified a total of 225 385 UP and 443 DN DEGs in all Mac2+ cells ( Fig 6C; Table S1 ). Among the DEGs, early terminology, a total of 7 different gene clusters were compared, which covered the entire 234 microglial developmental trajectory, from yolk sac (Cluster YS, day E10.5 -E12.5), early 235 microglia (Cluster E1/E2, day E10.5 -E14), pre-microglia (Cluster P1/P2, day E14 to postnatal 236 day 9), to adulthood (Cluster A1/A2, >1Mo) (Matcovitch-Natan et al., 2016). Remarkably, genes 237 associated with early development were highly enriched among the upregulated DEGs in the 238 Mac2+ cells ( Fig 6D) . Specifically, 16.36% of genes were those associated with yolk sac (YS) 239 progenitors and 22.60% of the genes were those expressed in early embryonic progenitors (E1), 240 while only around 2% of those expressed in adult microglia ( Fig 6D) . In contrast, among the 241 downregulated DEGs from Mac2+ cells, 19.64% and 27.09% of them overlapped with the A2 and 242 A1 adult gene signatures respectively (Fig. 6E) . As a control for the analysis, we also examined 243 the cells lacking Mac2 expression (Mac2-), which exhibit no progenitor signatures in them (Fig  244   S6 ). In direct contrast to Mac2+ cells, upregulated DEGs in Mac2-cells showed significant overlap 245 with adult microglia while the downregulated one with yolk sac (Fig S6) . We next questioned whether the Mac2+ cells in non-treated ctrl brain also have progenitor-like 259 features. Among all the Mac2+ cell from our scRNA-seq data, 3.01% came from the untreated ctrl 260 C57/BL6J mice ( Fig 7A) . Mac2+ cells from Ctrl mice exhibited similar upregulation of 261 developmental genes but downregulation of homeostatic markers compared to cluster-1 ( Fig 7B) . 262
Specifically, approximately 86.44% upregulated DEGs ( Fig 7C) and 93.67% downregulated 263 DEGs ( Fig 7D) from the Mac2+ cells in Ctrl brains were found in all Mac2+ cells, suggesting that 264 the properties of Mac2+ cells in the presence or absence of csf1r inhibition are indistinguishable. 265
Indeed, Mac2+ cells from the control brain exhibited similar microglial progenitor signatures with 266 reduced expression of mature microglial markers (Fig 7E, F) , further confirming the presence of 267 Mac2+ progenitor-like microglia in adult mouse brain. 268
DISCUSSION 269
In the current study, we employed scRNA-seq to characterize the CNS myeloid population under 270 acute Csf1r inhibition and identified a resistant microglia population that expresses Mac2 antigen. 271
In the hippocampus, the Mac2+ microglial sub-population represented 0.68% total microglia and 272 In characterizing the remaining microglia after acute Csf1r inhibition, we recovered a subset 293 of cells that can be distinguished by the Mac2 antigen that was also detectable under homeostatic 294 conditions. Unlike the vast majority of microglial population that is sensitive to Csf1r inhibitor, 295 the Mac2+ population modestly increased in response to the drug (Fig 4F) . 
Tissue preparation for microglia isolation 357
Four female mice (1 for Ctrl, 2 for D0, 1 for D2) were perfused with PBS transcardially to remove 358 circulating blood cells in the CNS. Whole brain was then dissected, with the cerebellum removed, 359 and homogenized in an enzymatic digestion buffer containing 0.2% Collagenase Type 3 360 (Worthington, LS004182) and 3 U/mL Dispase (Worthington, LS02104). The digestion was 361 performed at 37 °C for 45 min and quenched by an inactivation buffer containing 2.5 mM EDTA 362 (Thermofisher, 15575020) and 1% fetal bovine serum (Invitrogen, 10082147). The homogenates 363 were kept at 4°C for all downstream applications. The homogenates were then processed for 364 myelin depletion using myelin removal beads (Miltenyi Biotec, 130-096-733) and passed through 365 LD column (Miltenyi Biotec, 130-042-901). The myelin-depleted fraction was then used for 366
FACS. 367 368
Adult microglia purification via fluorescence-activated cell sorting (FACS) 369
To perform immune labeling, myelin-depleted cell suspensions were incubated with TruStain fcX 370 (BioLegend, Cat. No. 101319, clone 93) for 10 min at 4°C to block Fc receptors (1:50 dilution). 371
To label myeloid cells, the homogenates were incubated with a Cd11b antibody conjugated with 372 APC fluorophore for 20 min at 4°C (Tonbo bioscience, Cat: 20-0112, clone M1/70, 1:100 373 dilution). Sytox-blue live/dead stain (Thermofisher, S34857) was included 5 min before sorting 374
(1:1000 dilution). Cell suspensions were then sorted on a flow cytometer (BD FACSAria II). Live 375 Cd11b+ fraction was then sorted into pre-chilled RPMI-1640 media (Thermofisher Scientific, 376 12633012) containing 5% FBS. FACS gating strategy is shown in Supplementary Fig 1. The FACS 377 procedures were performed by the Gladstone Flow Core (Gladstone Institutes, San Francisco, 378 USA). 379 380
Single-cell cDNA library preparation and sequencing 381
Single-cell gene expression profiling was performed using the 10x Genomics platform according 382 to the manufacturer's instructions (10x Genomics, Pleasanton, CA, USA). FACS sorted cells were 383 captured in droplets that were emulsified with gel beads containing barcoded primers 384 (https://www.nature.com/articles/ncomms14049). Single-cell expression libraries were prepared 385 using the 10x genomics Chromium single cell 3′ library and gel bead kit v2 reagents (10x 386 Genomics, PN-120237). To minimize batch effects, all 4 samples were prepared simultaneously 387 in a single assay. Briefly, suspension containing 2,000-10,000 single cells were loaded into the 388 10x single cell A chip and processed in the 10x Chromium controller. After reverse transcription, The Illumina BCL output files were processed by the Cell Ranger software (2.0.1, 10x Genomics). 399
Sequencing reads were mapped to the mouse genome (mm10). A total of 2,149 cells were captured. 400
On average, 1,607 genes/cell and 4,632 UMIs/cell were detected. Over 94.6% reads were detected 401 in cells. Downstream gene profile analyses were performed using the Seurat package in R [Seurat 402 2.0, (Butler et al., 2018) ]. The data set was filtered based on the following criteria: 1) cells with 403 UMI count below 500 or above 20,000 were removed; 2) cells that have less than 200 genes were 404 removed; 3) cells that have greater than 10% mitochondrial genes were removed; (Supplementary 405 figure 2 a-d). In addition, we also removed genes that showed expression in less than 10 cells. 406
After data filtering, we obtained a total 2,100 cells for subsequent analysis (Fig 1c) . The data were 407 normalized by log transformation followed by regression based on total UMI counts and 408 mitochondrial gene content. Genes associated with principle components (1 to 22) were used for 409 data dimensional reduction based on tSNE to generate distinctive cell clusters ( Supplementary  410 figure 2e, f). Data visualization including heatmaps, tSNE plots, and violin plots, ridge plots were 411 generated using the following built-in functions from Seurat 2.0: "DoHeatmap", "FeaturePlot", 412 "VlnPlot", and "RidgePlot". Differentially expressed genes (DEGs) were performed using the 413 to unpaired t-test and Brown-Forsythe test was used to homoscedasticity prior to ANOVA. For 483 data with normal distribution and equal variance, unpaired t-test was used to compare two groups. 484
One-way ANOVA was used to compare data with more than two groups. Dunnett's multiple 485 comparisons test was used to compare difference between designated groups. Two-way ANOVA 486 with Dunnett's multiple comparisons test was used for multiple group comparison to Ctrl. For data 487 that failed to pass the normality test, Mann Whitney test was applied. For data with unequal 488 variance, unpaired t-test with Welch's correction was applied. P-value and FDR are summarized 489 as ns (p > 0.05); * (p £ 0.05); ** (p £ 0.01); *** (p £ 0.001); **** (p £ 0.0001). 
